SCHEMBL4040030

SCHEMBL4040030

CCCC(NC(=O)c1ccc(N2CCOCC2)cc1)C(=O)N1CCC2C1C(=O)CN2S(=O)(=O)C(=O)c1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSK P43235 11/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
PLOD2 O00469 1/20 0.37
PLOD3 O60568 1/20 0.37
PLOD1 Q02809 1/20 0.37
CTSL P07711 3/20 0.36
CTSS P25774 3/20 0.36
CTSV O60911 2/20 0.36
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
POLB P06746 1/20 0.35
CCR1 P32246 1/20 0.35
PREP P48147 1/20 0.35
FAP Q12884 1/20 0.35
ACACB O00763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048145 0.93 CTSK (0.47) CTSK
SCHEMBL4038890 0.92 CTSK (0.50) CTSKSMN1; SMN2TP53PLOD2PLOD3
SCHEMBL4044478 0.90 CTSK (0.42) CTSKSMN1; SMN2TP53CTSLCTSS
SCHEMBL4043857 0.90 CTSK (0.44) CTSKCTSLCTSSCTSVCCR1
SCHEMBL4040654 0.89 CTSK (0.41) CTSKCTSLCTSSCTSVMAPT
SCHEMBL4041145 0.89 CTSK (0.45) CTSKSMN1; SMN2TP53CTSLCTSS
SCHEMBL4040234 0.89 CTSK (0.54) CTSKCTSLCTSSCTSVNPC1
SCHEMBL4046752 0.88 CTSK (0.40) CTSKSMN1; SMN2TP53MAPT
SCHEMBL4041112 0.88 CTSK (0.46) CTSKCTSLCTSSCTSVCCR1
SCHEMBL4041463 0.88 CTSK (0.43) CTSKGAARAB9ACCR1PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-1546150-B1 PYRROLE DERIVATIVES AS INHIBITORS OF CYTEINE PROTEASES AMURA THERAPEUTICS LTD (GB) 2009-03-04 EP disclosed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed